Source link : https://www.newshealth.biz/health-news/fda-pushes-for-new-buprenorphine-labeling/
The US Food and Drug Administration (FDA) is urging manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses needed due to the rise of high-potency opioids like fentanyl. The agency published its proposal in the Federal Register in late December. The move comes on the heels of increasing evidence that […]
Author : News Health
Publish date : 2025-01-17 06:41:27
Copyright for syndicated content belongs to the linked Source.
inHealth